The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 37 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Wednesday 15 May: 14:45 – 15:45
The pharmaceutical industry’s business model is changing from a dichotomous model of one-off licensing with subsequent market entry to a progressive and flexible model of progressive patient access, with adaptive licensing and adaptive market entry. This session will explore how real-world data can support the new paradigm which will enable product launches starting with a limited indication in a limited patient population on the basis of limited clinical trial data, expanding as more clinical results become available from actual clinical practice.
Talk 1: The Need for a Change in the Industry’s Business Model
Edith Frénoy, Director Market Access, EFPIA
Talk 2: Data Mining to Support Progressive Patient Access
John Crawford, Healthcare Industry Leader Europe, IBM, UK
Dr. Matic Meglic, Head of Health Care, Informatics Centre, National Institute of Public Health
Q&A With the Audience